NOVAiCOS ImmunoTherapeutics is led by a team of professionals driven by passion and dedication to innovation and scientific research. We work together to develop groundbreaking solutions in the field of immunotherapy for bone health.
Pharmaceutical Chemist & Technologist, Former Pharma Business Head (Novartis & GE Healthcare groups)
MD, PhD, Professor of Immunology UniUPO
Researcher, Surgical Sciences UniTO
CFO - Novartis Group
President and CEO Bridge4Pharma s.r.l. Scientific and Strategic Partnering in R&D Programs
CEO Bridge4Pharma S.r.l. Scientific and Strategic Partnering in R&D Programs
MM Pharma Consulting Technology Transfer, CMC Project Management